Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
1 other identifier
interventional
24
1 country
1
Brief Summary
Obsessive-compulsive (OC) symptoms are often present among youth with Prader-Willi Syndrome (PWS). They are also associated with considerable problems in the daily functioning of the child and his/her family. Although medication and behavioral treatments exist that target OC symptoms among youth without PWS, these treatments have not been thoroughly adapted for this population nor scientifically tested. Although medication has been helpful in addressing OC symptoms in several published case reports, the associated efficacy is modest and the potential for side effects is a realistic concern. Given that behavioral treatment for OC symptoms has superior efficacy to pharmacotherapy in youth without PWS without the accompanying risk for adverse side effects, it follows that an adapted version of behavioral therapy may hold promise in treating clinically problematic OC symptoms in youth with PWS. Thus, the purpose of the proposed grant is to develop and pilot-test a behavioral treatment for OC symptoms for use in youth with PWS. This study will allow us to develop and test a treatment protocol aimed at reducing OC symptoms that are clinically problematic and negatively impact functioning and quality of life in the child and his/her family.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Sep 2008
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2008
CompletedFirst Posted
Study publicly available on registry
August 28, 2008
CompletedStudy Start
First participant enrolled
September 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedAugust 8, 2011
July 1, 2011
2.8 years
August 26, 2008
August 4, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS; Scahill et al., 1997).
Baseline, Mid-Treatment, Post-treatment
Secondary Outcomes (1)
Clinical Global Improvement (CGI; Guy, 1976).
Mid- and Post-treatment
Study Arms (2)
1
EXPERIMENTALWill receive 12 sessions of twice weekly psychotherapy targeting obsessive-compulsive symptoms.
2
PLACEBO COMPARATORInterventions
The manual is informed by behavioral principles and provides a structured, replicable manner of treating OC symptoms in youth with PWS. The treatment is individual in nature, includes a strong family component (i.e., teaching parents to be their child's coach/therapist), and lasts for approximately 12 sessions, held in a twice-weekly format. In addition, the protocol includes several specific components: education about OC symptoms (i.e., etiology, behavioral function, etc.), developing a hierarchy of rituals to target, exposure and response prevention exercises, promoting adaptive familial responses to child behaviors, and relapse prevention and problem solving future situations.
Eligibility Criteria
You may qualify if:
- The child must have a genetically confirmed diagnosis of PWS;
- CY-BOCS Compulsion Score ≥ 8. The Compulsion Scale Score is being used as youth with PWS may have difficulty understanding or identifying the connection between obsessional thoughts and subsequent rituals. Therefore, use of the Total Score may provide an inaccurate depiction of symptoms (Storch et al., 2005);
- Stable on any psychotropic medications for 8 weeks prior to study entry;
- Between the ages of 6 and 17 years as the present measures are valid for use in this age span;
- At least one parent available to accompany the child to all sessions; and
- English speaking.
You may not qualify if:
- Current suicidal intent or risk;
- A positive diagnosis in the caregiver of mental retardation, psychosis, or other psychiatric conditions that would limit their ability to understand psychotherapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of South Floridalead
- Johns Hopkins All Children's Hospitalcollaborator
Study Sites (1)
All Children's Hospital
St. Petersburg, Florida, 33701, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric Storch, Ph.D.
University of South Florida
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 26, 2008
First Posted
August 28, 2008
Study Start
September 1, 2008
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
August 8, 2011
Record last verified: 2011-07